Evolent Health completes stock purchase deal with Privia affiliate

Evolent Health, Inc. reported that its wholly owned subsidiary, Evolent Health LLC, has completed the transactions under a previously announced Stock Purchase Agreement with Privia Management Company, LLC.

Rhea-AI Filing Summary

Evolent Health, Inc. reported that its wholly owned subsidiary, Evolent Health LLC, has completed the transactions under a previously announced Stock Purchase Agreement with Privia Management Company, LLC. The agreement was originally dated September 23, 2025, and the deal was consummated on December 5, 2025. This filing simply confirms the closing of that stock purchase arrangement, indicating that the parties have carried out the terms that were agreed earlier in the year.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Evolent Health, Inc. (EVH) announce in this 8-K filing?

Evolent Health, Inc. disclosed that its wholly owned subsidiary, Evolent Health LLC, consummated the transactions under a previously announced Stock Purchase Agreement with Privia Management Company, LLC on December 5, 2025.

Who are the parties involved in Evolent Healths completed transaction?

The transaction was between Evolent Health LLC, a wholly owned subsidiary of Evolent Health, Inc., and Privia Management Company, LLC, under a Stock Purchase Agreement dated September 23, 2025.

When was the Stock Purchase Agreement related to EVHs transaction originally signed?

The Stock Purchase Agreement between Evolent Health LLC and Privia Management Company, LLC was dated September 23, 2025.

When did Evolent Health LLC consummate the stock purchase transaction?

Evolent Health LLC consummated the transactions contemplated by the Stock Purchase Agreement on December 5, 2025.

What is the relationship between Evolent Health LLC and Evolent Health, Inc. (EVH)?

Evolent Health LLC is described as a wholly owned subsidiary of Evolent Health, Inc. in the filing.

Did Evolent Health, Inc. disclose financial terms of the Privia transaction in this filing?

This report states that Evolent Health LLC consummated the transactions under the Stock Purchase Agreement with Privia Management Company, LLC, but it does not include specific financial terms in the provided content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/08/2025 - 08:00 AM Learn about SEC filing dates

December 5, 20250001628908false00016289082025-12-052025-12-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

FORM 8-K

_________________________

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

December 5, 2025

Date of Report (Date of earliest event reported)   

Evolent Health, Inc.

(Exact name of registrant as specified in its charter)

_________________________

			Delaware						001-37415																		32-0454912
			(State or other jurisdiction of incorporation)						Commission File Number:																		(I.R.S. Employer Identification No.)
			1812 N. Moore Street			,			Suite 1705			,			Arlington			,			Virginia			,			22209
			(Address of principal executive offices)(zip code)

(571) 389-6000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report.)

_________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock of Evolent Health, Inc., par value $0.01 per share

EVH

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 8.01    Other Events

On December 5, 2025, Evolent Health LLC, a wholly owned subsidiary of Evolent Health, Inc., consummated the transactions contemplated by the previously announced Stock Purchase Agreement, dated September 23, 2025, by and between Evolent Health LLC and Privia Management Company, LLC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EVOLENT HEALTH, INC.
By:			/s/ Jonathan D. Weinberg
Name:			Jonathan D. Weinberg
Title:			General Counsel and Secretary

Date: December 8, 2025